Some Mechanisms of FLIP Expression in Inhibition of HIV-1 Replication in Jurkat Cells, CD4+T Cells and PBMCs

被引:12
作者
Tan, Jiying [1 ]
Wang, Xue [1 ]
Devadas, Krishnakumar [1 ]
Zhao, Jiangqin [1 ]
Zhang, Panhe [1 ]
Hewlett, Indira [1 ]
机构
[1] US FDA, Mol Virol Lab, Div Emerging & Transfus Transmitted Dis, Ctr Biol Evaluat & Res, Bethesda, MD 20892 USA
关键词
IMMUNODEFICIENCY-VIRUS TYPE-1; LIPID RAFTS; MAP KINASE; P38; ACTIVATION; PROTEIN; TRANSCRIPTION; MICRODOMAINS; APOPTOSIS; PATHWAYS;
D O I
10.1002/jcp.24397
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
HIV-1 infection and replication are affected by host factors. Recent studies demonstrate that molecules from apoptotic pathways regulate HIV-1 replication. Therefore, studies on effects of host factors that maintain host cell survival and influence HIV-1 replication are critical to understanding the mechanisms of HIV-1 replicative cycle. Using the susceptible Jurkat cell line, CD4(+) T cells, and peripheral blood mononuclear cells (PBMCs), we studied the role of FLIP, an inhibitor of caspase-8, in HIV-1 production. Full length cellular FLIP (cFLIP) inhibited HIV-1 replication in these cells. cFLIP upregulated the expression of viral restriction factors, such as TRIM5, Apobec3G, and Bst2/tetherin, decreased nuclear factor 1C expression and inactivated ERK and p38 induced by HIV-1 in Jurkat cells. cFLIP blocked the trafficking of gp120 and Gag p24 capsid protein into lipid rafts with inhibition of Tsg101 and Alix in ESCRT signaling pathway. cFLIP also promoted Bst2/tetherin trafficking into lipid rafts. These results indicate that cFLIP may inhibit the HIV-1 replication cycle at multiple steps, including viral RNA release, transcription, traffic and assembly. We also found that cFLIP expression downregulated Fas expression and inactivated FADD in the Fas-mediated apoptotic pathway. The inactivated FADD also inhibited HIV-1 replication. J. Cell. Physiol. 228: 2305-2313, 2013. (c) 2013 Wiley Periodicals, Inc.
引用
收藏
页码:2305 / 2313
页数:9
相关论文
共 39 条
[1]   Novel approaches to inhibiting HIV-1 replication [J].
Adamson, Catherine S. ;
Freed, Eric O. .
ANTIVIRAL RESEARCH, 2010, 85 (01) :119-141
[2]   Interactions of host APOBEC3 restriction factors with HIV-1 in vivo: implications for therapeutics [J].
Albin, John S. ;
Harris, Reuben S. .
EXPERT REVIEWS IN MOLECULAR MEDICINE, 2010, 12
[3]   Role of cytokines and chemokines in the regulation of innate immunity and HIV infection [J].
Alfano, M ;
Poli, G .
MOLECULAR IMMUNOLOGY, 2005, 42 (02) :161-182
[4]   New Insights into HIV Assembly and Trafficking [J].
Balasubramaniam, Muthukumar ;
Freed, Eric O. .
PHYSIOLOGY, 2011, 26 (04) :236-251
[5]   Lipid rafts and HIV-1: from viral entry to assembly of progeny virions [J].
Campbell, SM ;
Crowe, SM ;
Mak, J .
JOURNAL OF CLINICAL VIROLOGY, 2001, 22 (03) :217-227
[6]   HIV entry and its inhibition [J].
Chan, DC ;
Kim, PS .
CELL, 1998, 93 (05) :681-684
[7]   The critical role of p38 MAP kinase in T cell HIV-I replication [J].
Cohen, PS ;
Schmidtmayerova, H ;
Dennis, J ;
Dubrovsky, L ;
Sherry, B ;
Wang, HC ;
Bukrinsky, M ;
Tracey, KJ .
MOLECULAR MEDICINE, 1997, 3 (05) :339-346
[8]   HIV-1: Fifteen proteins and an RNA [J].
Frankel, AD ;
Young, JAT .
ANNUAL REVIEW OF BIOCHEMISTRY, 1998, 67 :1-25
[9]  
Freed Eric O., 2001, Somatic Cell and Molecular Genetics, V26, P13, DOI 10.1023/A:1021070512287
[10]   Signaling through the P38 and ERK pathways: a common link between HIV replication and the immune response [J].
Furler, Robert L. ;
Uittenbogaart, Christel H. .
IMMUNOLOGIC RESEARCH, 2010, 48 (1-3) :99-109